Annie Kaufman serves as the CEO of NorthMed. In her previous role, Annie led Collaborations and Partnerships at Biosense Webster, part of Johnson & Johnson MedTech.
She has held multiple leadership positions across the medical and technology sectors, including roles at Medingo (a medical startup acquired by Roche), Surf Communication (a technology startup acquired by Lynx), and Syneron-Candela, a publicly traded NASDAQ company. Over the years, she has built a strong track record as VP of R&D, Senior Business Development Manager, and Global VP of Product and Upstream Marketing.
Annie holds a B.Sc. in Computer Science from the Technion – Israel Institute of Technology and a Global MBA in Healthcare Innovation from Reichman University.